About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 935289, 18 pages
http://dx.doi.org/10.1155/2013/935289
Review Article

Etiologic Aspect of Sarcoidosis as an Allergic Endogenous Infection Caused by Propionibacterium acnes

Department of Human Pathology, Tokyo Medical and Dental University Graduate School, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan

Received 12 January 2013; Accepted 7 May 2013

Academic Editor: Peter A. Lambert

Copyright © 2013 Yoshinobu Eishi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Newman, C. S. Rose, and L. A. Maier, “Sarcoidosis,” The New England Journal of Medicine, vol. 336, no. 17, pp. 1224–1234, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. G. W. Hunninghake, U. Costabel, M. Ando et al., “ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders,” Sarcoidosis Vasculitis and Diffuse Lung Disease, vol. 16, no. 2, pp. 149–173, 1999. View at Scopus
  3. R. P. Baughman, E. E. Lower, and R. M. du Bois, “Sarcoidosis,” The Lancet, vol. 361, no. 9363, pp. 1111–1118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. S. Newman, C. S. Rose, E. A. Bresnitz et al., “A case control etiologic study of sarcoidosis: environmental and occupational risk factors,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 12, pp. 1324–1330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. McGrath, N. Goh, P. J. Foley, and R. M. du Bois, “Sarcoidosis: genes and microbes—soil or seed?” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 18, no. 2, pp. 149–164, 2001. View at Scopus
  6. R. M. du Bois, N. Goh, D. McGrath, and P. Cullinan, “Is there a role for microorganisms in the pathogenesis of sarcoidosis?” Journal of Internal Medicine, vol. 253, no. 1, pp. 4–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. W. P. Drake and L. S. Newman, “Mycobacterial antigens may be important in sarcoidosis pathogenesis,” Current Opinion in Pulmonary Medicine, vol. 12, no. 5, pp. 359–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Eishi, M. Suga, I. Ishige et al., “Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis,” Journal of Clinical Microbiology, vol. 40, no. 1, pp. 198–204, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Brownell, F. Ramírez-Valle, M. Sanchez, and S. Prystowsky, “Evidence for mycobacteria in sarcoidosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 5, pp. 899–905, 2011. View at Publisher · View at Google Scholar
  10. W. P. Drake, M. S. Dhason, M. Nadaf et al., “Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis,” Infection and Immunity, vol. 75, no. 1, pp. 527–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ebe, S. Ikushima, T. Yamaguchi et al., “Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 17, no. 3, pp. 256–265, 2000. View at Scopus
  12. K. A. Oswald-Richter, D. C. Beachboard, E. H. Seeley, et al., “Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL,” Journal of Clinical Immunology, vol. 32, no. 5, pp. 1129–1140, 2012. View at Publisher · View at Google Scholar
  13. A. Zumla and D. G. James, “Granulomatous infections: etiology and classification,” Clinical Infectious Diseases, vol. 23, no. 1, pp. 146–158, 1996. View at Scopus
  14. J. Y. Homma, C. Abe, H. Chosa, et al., “Bacteriological investigation on biopsy specimens from patients with sarcoidosis,” Japanese Journal of Experimental Medicine, vol. 48, no. 3, pp. 251–255, 1978. View at Scopus
  15. C. Abe, K. Iwai, R. Mikami, and Y. Hosoda, “Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes,” Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A, vol. 256, no. 4, pp. 541–547, 1984. View at Scopus
  16. M. Conron and R. M. du Bois, “Immunological mechanisms in sarcoidosis,” Clinical and Experimental Allergy, vol. 31, no. 4, pp. 543–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Agostini, A. Meneghin, and G. Semenzato, “T-lymphocytes and cytokines in sarcoidosis,” Current Opinion in Pulmonary Medicine, vol. 8, no. 5, pp. 435–440, 2002. View at Scopus
  18. I. Ishige, Y. Eishi, T. Takemura et al., “Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 22, no. 1, pp. 33–42, 2005. View at Scopus
  19. A. Furukawa, K. Uchida, Y. Ishige et al., “Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism,” Microbial Pathogenesis, vol. 46, no. 2, pp. 80–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. R. Cue and P. P. Cleary, “High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD,” Infection and Immunity, vol. 65, no. 7, pp. 2759–2764, 1997. View at Scopus
  21. H. M. Fidler, G. A. Rook, N. M. Johnson, and J. McFadden, “Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis,” British Medical Journal, vol. 306, no. 6877, pp. 546–549, 1993. View at Scopus
  22. H. H. Popper, E. Winter, and G. Höfler, “DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction,” American Journal of Clinical Pathology, vol. 101, no. 6, pp. 738–741, 1994. View at Scopus
  23. S. A. Saboor, M. N. Johnson, and J. McFadden, “Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction,” The Lancet, vol. 339, no. 8800, pp. 1012–1015, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Bocart, D. Lecossier, A. de Lassence, D. Valeyre, J. P. Battesti, and A. J. Hance, “A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction,” American Review of Respiratory Disease, vol. 145, no. 5, pp. 1142–1148, 1992. View at Scopus
  25. E. Richter, U. Greinert, D. Kirsten et al., “Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 375–380, 1996. View at Scopus
  26. M. Vokurka, D. Lecossier, R. M. du Bois et al., “Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 3, part 1, pp. 1000–1003, 1997. View at Scopus
  27. I. Ishige, Y. Usui, T. Takemura, and Y. Eishi, “Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis,” The Lancet, vol. 354, no. 9173, pp. 120–123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yamada, Y. Eishi, S. Ikeda et al., “In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition,” Journal of Pathology, vol. 198, no. 4, pp. 541–547, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Negi, T. Takemura, J. Guzman, et al., “Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium,” Modern Pathology, vol. 25, no. 9, pp. 1284–1297, 2012. View at Publisher · View at Google Scholar
  30. J. F. Boyd and J. C. Valentine, “Unidentified yellow bodies in human lymph-nodes,” Journal of Pathology, vol. 102, no. 1, pp. 58–60, 1970. View at Scopus
  31. W. F. Doyle, H. D. Brahman, and J. H. Burgess, “The nature of yellow brown bodies in peritoneal lymph nodes. Histochemical and electron microscopic evaluation of these bodies in a case of suspected sarcoidosis,” Archives of Pathology and Laboratory Medicine, vol. 96, no. 5, pp. 320–326, 1973. View at Scopus
  32. E. A. Moscovic, “Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes,” Pathology Annual, vol. 13, part 2, pp. 69–164, 1978. View at Scopus
  33. L. E. Siltzbach, “The Kveim test in sarcoidosis. A study of 750 patients,” The Journal of the American Medical Association, vol. 178, pp. 476–482, 1961. View at Scopus
  34. G. W. Hunninghake and R. G. Crystal, “Pulmonary sarcoidosis. A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity,” The New England Journal of Medicine, vol. 305, no. 8, pp. 429–434, 1981. View at Scopus
  35. D. R. Moller, J. D. Forman, M. C. Liu et al., “Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis,” Journal of Immunology, vol. 156, no. 12, pp. 4952–4960, 1996. View at Scopus
  36. H. Furusawa, Y. Suzuki, Y. Miyazaki, N. Inase, and Y. Eishi, “Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis,” Respiratory Investigation, vol. 50, no. 3, pp. 104–109, 2012. View at Publisher · View at Google Scholar
  37. Y. Nakata, T. Ejiri, T. Kishi et al., “Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients,” Acta Medica Okayama, vol. 40, no. 5, pp. 257–264, 1986. View at Scopus
  38. Y. Mori, Y. Nakata, M. Kataoka et al., “Interleukin-2 production and receptor expression of alveolar lymphocytes stimulated by Propionibacterium acnes in sarcoidosis,” Nihon Kyobu Shikkan Gakkai Zasshi, vol. 27, no. 1, pp. 42–50, 1989. View at Scopus
  39. J. I. Hiramatsu, M. Kataoka, Y. Nakata et al., “Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 20, no. 3, pp. 197–203, 2003. View at Scopus
  40. Y. Ogura, D. K. Bonen, N. Inohara et al., “A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 603–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Miceli-Richard, S. Lesage, M. Rybojad et al., “CARD15 mutations in Blau syndrome,” Nature Genetics, vol. 29, no. 1, pp. 19–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Kanazawa, I. Okafuji, N. Kambe et al., “Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: common genetic etiology with Blau syndrome,” Blood, vol. 105, no. 3, pp. 1195–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Schürmann, R. Valentonyte, J. Hampe, J. Müller-Quernheim, E. Schwinger, and S. Schreiber, “CARD15 gene mutations in sarcoidosis,” European Respiratory Journal, vol. 22, no. 5, pp. 748–754, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Tanabe, I. Ishige, Y. Suzuki et al., “Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes,” Biochimica et Biophysica Acta, vol. 1762, no. 9, pp. 794–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Nagy, A. Pivarcsi, A. Koreck, M. Széll, E. Urbán, and L. Kemény, “Distinct strains of Propionibacterium acnes induce selective human β-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors,” Journal of Investigative Dermatology, vol. 124, no. 5, pp. 931–938, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Kalis, M. Gumenscheimer, N. Freudenberg et al., “Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes,” Journal of Immunology, vol. 174, no. 7, pp. 4295–4300, 2005. View at Scopus
  47. P. K. Boughan, R. H. Argent, M. Body-Malapel et al., “Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of β-defensins during Helicobacter pylori infection,” Journal of Biological Chemistry, vol. 281, no. 17, pp. 11637–11648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Senaldi, S. Yin, C. L. Shaklee, P. F. Piguet, T. W. Mak, and T. R. Ulich, “Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI,” Journal of Immunology, vol. 157, no. 11, pp. 5022–5026, 1996. View at Scopus
  49. H. Tsuji, A. Harada, N. Mukaida et al., “Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis,” Infection and Immunity, vol. 65, no. 5, pp. 1892–1898, 1997. View at Scopus
  50. H. Yoneyama, K. Matsuno, Y. Zhang et al., “Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease,” Journal of Experimental Medicine, vol. 193, no. 1, pp. 35–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. E. S. Yi, H. Lee, Y. K. Suh et al., “Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats,” American Journal of Pathology, vol. 149, no. 4, pp. 1303–1312, 1996. View at Scopus
  52. H. Ichiyasu, M. Suga, K. Iyonaga, and M. Ando, “Role of monocyte chemoattractant protein-1 in Propionibacterium acnes-induced pulmonary granulomatosis,” Microscopy Research and Technique, vol. 53, no. 4, pp. 288–297, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Minami, Y. Eishi, Y. Ishige et al., “Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes,” Journal of Medical and Dental Sciences, vol. 50, no. 4, pp. 265–274, 2003. View at Scopus
  54. R. H. Swanborg, “Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity,” Immunological Reviews, vol. 184, pp. 129–135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Goulvestre, F. Batteux, and J. Charreire, “Chemokines modulate experimental autoimmune thyroiditis through attraction of autoreactive or regulatory T cells,” European Journal of Immunology, vol. 32, no. 12, pp. 3435–3442, 2002.
  56. C. Teuscher, W. F. Hickey, C. M. Grafer, and K. S. K. Tung, “A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/C mice,” Journal of Immunology, vol. 160, no. 6, pp. 2751–2756, 1998. View at Scopus
  57. T. Nishiwaki, H. Yoneyama, Y. Eishi et al., “Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice,” American Journal of Pathology, vol. 165, no. 2, pp. 631–639, 2004. View at Scopus
  58. A. Casadevall and L. A. Pirofski, “Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity,” Infection and Immunity, vol. 67, no. 8, pp. 3703–3713, 1999. View at Scopus
  59. K. Iwai, T. Takemura, M. Kitaichi, Y. Kawabata, and Y. Matsui, “Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern,” Acta Pathologica Japonica, vol. 43, no. 7-8, pp. 377–385, 1993. View at Scopus
  60. P. L. Lin and J. L. Flynn, “Understanding latent tuberculosis: a moving target,” Journal of Immunology, vol. 185, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Tufariello, J. Chan, and J. L. Flynn, “Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection,” Lancet Infectious Diseases, vol. 3, no. 9, pp. 578–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Keane, S. Gershon, R. P. Wise et al., “Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent,” The New England Journal of Medicine, vol. 345, no. 15, pp. 1098–1104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Gifre, V. Ruiz-Esquide, A. Xaubet, J. A. Gómez-Puerta, M. V. Hernández, and R. Sanmartí, “Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review,” Archivos de Bronconeumologia, vol. 47, no. 4, pp. 208–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Keane, “TNF-blocking agents and tuberculosis: new drugs illuminate an old topic,” Rheumatology, vol. 44, no. 6, pp. 714–720, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. J. E. Gottlieb, H. L. Israel, R. M. Steiner, J. Triolo, and H. Patrick, “Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy,” Chest, vol. 111, no. 3, pp. 623–631, 1997. View at Scopus
  66. H. Bachelez, P. Senet, J. Cadranel, A. Kaoukhov, and L. Dubertret, “The use of tetracyclines for the treatment of sarcoidosis,” Archives of Dermatology, vol. 137, no. 1, pp. 69–73, 2001. View at Scopus
  67. K. Baba, E. Yamaguchi, S. Matsui et al., “A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 23, no. 1, pp. 78–79, 2006. View at Scopus
  68. D. J. J. Park, J. J. Woog, J. S. Pulido, and J. D. Cameron, “Minocycline for the treatment of ocular and ocular adnexal sarcoidosis,” Archives of Ophthalmology, vol. 125, no. 5, pp. 705–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Miyazaki, M. Ando, T. Fukami, S. I. Nureki, Y. Eishi, and T. Kumamoto, “Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?” Clinical Rheumatology, vol. 27, no. 9, pp. 1195–1197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. N. B. Esterly, J. S. Koransky, N. L. Furey, and M. Trevisan, “Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy,” Archives of Dermatology, vol. 120, no. 10, pp. 1308–1313, 1984. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Kloppenburg, C. L. Verweij, A. M. M. Miltenburg et al., “The influence of tetracyclines on T cell activation,” Clinical and Experimental Immunology, vol. 102, no. 3, pp. 635–641, 1995. View at Scopus
  72. G. F. Webster, S. M. Toso, and L. Hegemann, “Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin: involvement of protein kinase C,” Archives of Dermatology, vol. 130, no. 6, pp. 748–752, 1994. View at Publisher · View at Google Scholar · View at Scopus
  73. T. G. Marshall and F. E. Marshall, “Sarcoidosis succumbs to antibiotics—implications for autoimmune disease,” Autoimmunity Reviews, vol. 3, no. 4, pp. 295–300, 2004. View at Publisher · View at Google Scholar · View at Scopus